NVS is holding an oncology CC on Monday at 11am ET to discuss data presented at both ASH and SABCS. Access to the webcast is at: <a href="http://www.novartis.com/investors/presentations-events/index.shtml#2008-12-15-oncology" target="_blank">http://www.novartis.com/investors/presentations-events/index.shtml#2008-12-15-oncology</a> The protagonists: RAD001 and Tasigna (ASH); Femara and Zometa (SABCS).